Literature DB >> 6725495

Determination of urinary succinylacetone by capillary gas chromatography.

M Tuchman, C B Whitley, M L Ramnaraine, L D Bowers, K D Fregien, W Krivit.   

Abstract

The average analytical recovery of succinylacetone added to urine and separated by capillary gas chromatography was 69% for solvent extraction and 72% for anion exchange separation. Treating succinylacetone with hydroxylamine hydrochloride at a pH of less than 5 caused formation of a derivative separated by capillary gas chromatography into two isomers: 3-methyl-5- isoxazole propionate and 5-methyl-3- isoxazole propionate as their trimethylsilyl derivatives (molecular weight 227). In a pH greater than or equal to 5, succinylacetone dioxime was formed and separated into 3 isomers as their trimethylsilyl derivatives (molecular weight 404). Succinylacetone dioxime was converted to 3(5)-methyl-(3)5- isoxazole propionate whenever the pH of the solution was dropped to less than 5. Mass spectra of both derivatives are shown. This study demonstrates that capillary gas chromatography is suitable for use in urinary succinylacetone determination.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725495     DOI: 10.1093/chromsci/22.5.211

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  6 in total

1.  Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.

Authors:  E Riudor; A Ribes; J Lloret; J Friden; E Holme; C Jakobs; V Martinez Ibanez
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.

Authors:  J L Aponte; G A Sega; L J Hauser; M S Dhar; C M Withrow; D A Carpenter; E M Rinchik; C T Culiat; D K Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

3.  Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I.

Authors:  S Z Kim; K G Kupke; L Ierardi-Curto; E Holme; J Greter; R M Tanguay; J Poudrier; M D'Astous; F Lettre; S H Hahn; H L Levy
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

4.  Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I.

Authors:  M Tuchman; D K Freese; H L Sharp; C B Whitley; M L Ramnaraine; R A Ulstrom; J S Najarian; N Ascher; N R Buist; A B Terry
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

5.  Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism.

Authors:  José Manuel Fernández-Cañón; Manfred W Baetscher; Milton Finegold; Terry Burlingame; K Michael Gibson; Markus Grompe
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

6.  Plasma succinylacetone is persistently raised after liver transplantation in tyrosinaemia type 1.

Authors:  David C Bartlett; Mary Anne Preece; Elisabeth Holme; Carla Lloyd; Phil N Newsome; Patrick J McKiernan
Journal:  J Inherit Metab Dis       Date:  2012-03-29       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.